亚太药业: 关于股票交易异常波动公告
Group 1 - The stock of Zhejiang Apac Pharmaceutical Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from July 16 to July 18, 2025 [1] - The company conducted verification regarding the stock price fluctuation and confirmed that there are no undisclosed significant matters affecting the stock price [1] - The board of directors confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange regulations, and previous disclosures do not require correction or supplementation [1]